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Abstract Background Female sex is known to have increased perioperative mortality in cardiac
surgery. Studies reporting effects of sex on outcome following surgical repair for acute
Type A aortic dissection (ATAAD) have been limited by small cohorts of heterogeneous
patient populations and have shown diverging results. This study aimed to compare
perioperative characteristics, operative management, and postoperative outcome
between sexes in a large and well-defined cohort of patients operated for ATAAD.
Methods The Nordic Consortium for Acute Type A Aortic Dissection study included
patients with surgical repair of ATAAD at eight Nordic centers between January 2005
and December 2014. Independent predictors of 30-day mortality were identified using
multivariable logistic regression.
Results Females represented373 (32%) outof 1,154patients andwere significantlyolder
(65  11 vs. 60  12 years, p < 0.001), had lower body mass index (25.8  5.4 vs.
27.2  4.3 kg/m2, p < 0.001), and hadmore often a history of hypertension (59% vs. 48%,
p ¼ 0.001) and chronic obstructive pulmonary disease (8% vs. 4%, p ¼ 0.033) compared
with males. More females presented with DeBakey class II as compared with males with
dissection of the ascending aorta alone (33.4% vs. 23.1%, p ¼ 0.003). Hypothermic cardiac
arrest time (28  16 vs. 31  19minutes, p ¼ 0.026) and operation time (345  133 vs.
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Introduction
Acute Type A aortic dissection (ATAAD) is a lethal cardiovas-
cular emergency forwhich surgical repair is essential.1Despite
significant improvements in perioperative management over
the past decades, surgery for ATAAD is still associated with
high mortality and morbidity.2 Several factors, such as
advanced age and comorbidities including diabetes and
chronic obstructive pulmonary disease (COPD), preoperative
cardiogenic shock with or without cardiac tamponade, and
longer cardiopulmonary bypass (CPB) time, have been sug-
gested as independent predictors of poor outcome.3–5
Sex differences have previously been shown to influence
outcomesfollowingcardiacsurgery.6,7 In theriskmodelsofboth
theSocietyofThoracic SurgeonsscoreandtheEuropeanSystem
for Cardiac Operative Risk Evaluation, female sex is a risk factor
for early mortality after cardiac surgery.6–8 In spite of sex
differences being well documented in patients undergoing
cardiac surgery, there have been few reports that specifically
compare outcomes for males and females following surgical
repair for ATAAD. Of the reported studies, some have found
female sex to be an independent predictor of mortality after
surgical repair forATAAD,3,9,10whileothers foundnosignificant
association between sex and outcome.4,5,11 The previous stu-
dies havebeen limited by small cohorts of heterogeneous study
samples andhave showndiverging results. This report fromThe
Nordic Consortium for Acute Type A Dissection (NORCAAD)
constitutes one of the largest studies investigating the impactof
sexdifferences onoutcome following surgical repair for ATAAD.
The aim of this study was to determine the impact of sex on
preoperative characteristics, operative management, and post-
operative outcomes in a large multicenter cohort of patients
who underwent surgical treatment for ATAAD.
Materials and Methods
The study is a part of NORCAAD, which includes eight centers
in Denmark, Finland, Iceland, and Sweden. The study setup is
further described elsewhere.12 In brief, data were retrospec-
tively collected for adult patients (> 17 years of age) who
underwent surgery for ATAAD between January 1, 2005 and
December31, 2014at the following centers: AarhusUniversity
Hospital, Skejby, Denmark; Karolinska University Hospital,
Stockholm, Sweden; Landspitali University Hospital, Reykja-
vik, Iceland; Orebro University Hospital, Orebro, Sweden;
Sahlgrenska University Hospital, Gothenburg, Sweden; Skane
University Hospital, Lund, Sweden; Tampere University Hos-
pital, Tampere, Finland; and Turku University Hospital, Turku,
Finland. A total of 194 clinical variables were retrospectively
collected, including demographics, past medical history, pre-
operative medications, clinical symptoms at presentation,
methods of diagnosis, operative variables, complications,
bleeding and blood transfusion, laboratory values, and out-
come data. The length of stay was recorded as days in the
intensive care unit and in the general ward.
The study was approved by each of the participating
institutions. Patients were deidentified prior to inclusion
into the database. As individual patients were not identified,
obtaining individual consent for the study was waived.
Statistics
Datawere examined for normal distribution using the Shapiro–
Wilk test. Comparisons of two groups were performed with
Mann–Whitney U test for continuous variables. Nonordered
categorical variables were compared with Pearson’s chi-
squared test and dichotomous variables with Fisher’s exact
test. All tests were two-tailed and conducted at a 0.05 signifi-
cance level. Data are presented as mean  standard deviation,
medianwith25thto75thpercentile (interquartile range)where
applicable or number (percentage). Independent predictors of
mortality were identified with odds ratio (OR) with 95% con-
fidence interval (CI) estimated with a multivariable logistic
regression. All variables were adjusted for age. The variables
included in the multivariate analysis were selected based
on degree of significance (p < 0.20) from the univariate and
age-adjustedanalysis.All statistical analyseswereperformedby
a professional statistician using SAS Software version 9.4 (SAS
Institute Inc., Cary, NC).
Results
A total of 1,154 patients were included in the study, of which
373 (32%) were females and 781 (68%) weremales. Themean
age for the cohort was 61  12 years. Poisson regression and
Cox proportional hazard analysis are found in the
►Supplementary Tables 1 and 2, respectively.
Patient Characteristics
Patient characteristics are outlined in ►Table 1. Females
were significantly older (65  11 vs. 60  12 years,
p < 0.001), had lower body mass index (BMI) (26  5 vs.
27  4 kg/m2, p < 0.001), and more often had a history of
374  135 minutes, p < 0.001) were shorter among females. There was no difference
between the sexes in unadjusted intraoperative death (9.1% vs. 6.7%, p ¼ 0.17) or 30-day
mortality (17.7% vs. 17.4%, p ¼ 0.99). In a multivariable analysis including perioperative
factors influencingmortality, nodifferencewas foundbetween females andmales in30-day
mortality (odds ratio: 0.92, 95% confidence interval: 0.62–1.38, p ¼ 0.69).
Conclusions This study found no association between sex and early mortality
following surgery for ATAAD, despite females being older and having more comorbid-
ities, yet also presenting with a less widespread dissection than males.
AORTA Vol. 7 No. 1/2019
The Nordic Consortium for Acute Aortic Dissection Chemtob et al.8
hypertension (58.9% vs. 48.3%, p ¼ 0.001) and COPD (8.3% vs.
4.9%, p ¼ 0.03) as compared with males. Furthermore, there
was a trend toward increased rates of hypercholesterolemia
(14.2% vs. 10.6%, p ¼ 0.09) and preoperative pericardial
tamponade (19.2% vs. 15.7%, p ¼ 0.08) among females.
Although within the normal range, females had lower pre-
operative creatinine levels thanmales (80  28 vs. 106  58
μmol/L, p < 0.001).
Perioperative Characteristics
The perioperative characteristics are outlined in ►Tables 2
and 3. The median time from symptom presentation to
definitive surgical treatment was 2.3 (1.0; 7.0) hours and
2.9 (1.0; 6.7) hours in females (n ¼ 208) and males
(n ¼ 441), respectively (p ¼ 0.72). However, data on time
delay were missing in 165 (44%) females and 441 (56%) of
males. Furthermore, females had shorter operation time
(345  133 vs. 374  134.8 minutes, p < 0.001), CPB time
(198  77 vs. 212  79 minutes, p < 0.001), aortic cross-
clamp time (99  54 vs. 109  57 minutes, p < 0.001), and
hypothermic circulatory arrest (HCA) time (28  16 vs.
31  19 minutes, p ¼ 0.02) as compared with males. In
addition, significantly fewer females compared with males
had surgical repair with a biological aortic valve replacement
Table 1 Patient characteristics
Variables Male (n ¼ 781) Female (n ¼ 373) p-Value
Age 59.9 (12.2) 62.0 (14.0; 86.0)
n ¼ 781
65.0 (11.3) 66.0 (18.0; 85.0)
n ¼ 373
< 0.0001
Age > 70 y 157 (20.1%) 134 (35.9%) < 0.0001
Body mass index 27.2 (4.3) 26.2 (18.0; 47.7)
n ¼ 648
25.8 (5.4) 24.8 (11.4; 53.9)
n ¼ 308
< 0.0001
Smoking 242 (44.2%) 129 (43.0%) 0.80
Hypertension 377 (48.3%) 219 (58.9%) 0.0010
Hypercholesterolemia 82 (10.6%) 53 (14.2%) 0.092
Diabetes mellitus II 15 (1.9%) 11 (3.0%) 0.37
COPD 38 (4.9%) 31 (8.3%) 0.033
HxStroke 30 (3.9%) 17 (4.6%) 0.67
HxTIA 14 (1.8%) 3 (0.8%) 0.29
HxCKD 17 (2.2%) 4 (1.1%) 0.28
HxAfib 23 (6.8%) 4 (2.4%) 0.052
Marfan syndrome 33 (4.2%) 16 (4.3%) 1.00
Preoperative creatinine (µmol/L) 105.7 (57.9)95.0 (6.2; 1000.0)
n ¼ 635
80.5 (28.2)75.0 (36.0; 285.0)
n ¼ 324
< 0.0001
Euroscore II 10.5 (11.2)7.3 (1.0; 65.4)
n ¼ 219
9.35 (6.43)8.50 (0.62; 27.90)
n ¼ 84
0.35
LVEF TEE (%) 49.1 (8.3)50.0 (0.5; 74.0)
n ¼ 272
48.4 (8.6)50.0 (0.0; 70.0)
n ¼ 130
0.37
Cardiac arrest 39 (5.0%) 18 (4.8%) 1.00
Cardiogenic shock 161 (22.3%) 91 (26.1%) 0.19
Pericardial tamponade 120 (15.7%) 70 (19.2%) 0.17
DeBakey class:
I 596 (76.9%) 247 (66.6%)
II 179 (23.1%) 124 (33.4%) 0.0003
Penn Class:
Penn Class A 462 (59.7%) 243 (65.7%)
Penn Class B 182 (23.5%) 63 (17.0%)
Penn Class C 85 (11.0%) 41 (11.1%)
Penn Class B and C 45 (5.8%) 23 (6.2%) 0.092
Abbreviations: Afib, atrial fibrillation; CKD, chronic kidney disease; COPD, chronic obstructive pulmonary disease; Hx, history of; LVEF, left ventricular
ejection fraction; SD, standard deviation; TEE, transthoracic echocardiogram; TIA, transient ischemic attack.
Note: Data are presented as n (%) or mean (SD) / median (min; max).
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(3.8% vs. 7.1%, p ¼ 0.03) and less often underwent repair
using a mechanical composite graft (10.2% vs. 21%,
p < 0.001). Surgical repair with valve resuspension, how-
ever, was more common among females as compared with
males (44.2% vs. 37.3%, p ¼ 0.001).
Outcome Measures
Surgical outcome and postoperative complications are shown
in►Table 3. Reoperation forbleedingwas lesscommonamong
females than in males (16.5% vs. 23.9%, p ¼ 0.005). No differ-
ence was observed in intraoperative death among females as
compared with males (9.1% vs. 6.7%, p ¼ 0.17), death at
discharge (16.4% vs. 16.4%, p ¼ 1.00), or 30-day mortality
(17.4% vs. 17.7%, p ¼ 0.99).
In a multivariable logistic regression analysis for 30-day
mortality (►Table 4), no difference was found between
females and males in 30-day mortality (OR: 0.92, 95% CI:
0.62–1.38, p ¼ 0.69).
Discussion
In thisstudy,wefoundnosex-relateddifference inearlysurvival
among patients who had undergone surgical repair for ATAAD.
Females represented one-third of the cohort and were on
average 5 years older, had lower BMI, and had more frequently
a historyof hypertension andCOPD. Furthermore, CPB andHCA
times were shorter among females, who less frequently under-
went aortic valve replacement, compared with males.
Female sex has previously been suggested as a risk factor
in patients undergoing surgical repair for ATAAD. However,
most previous reports have included small cohorts, often
involving heterogeneous patient populations, and have
Table 2 Intraoperative characteristics
Variables Male (n ¼ 781) Female (n ¼ 373) p-Value
Operation time 373.6 (134.8) 344.0
(36.0; 1059.0)n ¼ 627
344.8 (133.3) 310.0
(15.0; 1100.0)n ¼ 295
0.0001
Cardiopulmonary bypass
time
211.6 (79.0) 197.0 (0.0; 715.0)n ¼ 714 197.7 (77.4) 178.5
(22.0; 500.0)n ¼ 344
< 0.0001
Cardiac arrest time 30.9 (18.8) 27.0 (0.0; 185.0)n ¼ 602 28.1 (16.5) 26.0
(0.0; 195.0)n ¼ 300
0.026
Temperature at cardiac
arrest
21.0 (4.9) 19.0 (11.0; 36.4)n ¼ 694 20.8 (4.6) 19.5
(13.0; 35.8)n ¼ 340
0.76
Cross-clamp time 109.2 (57.6) 96.0 (0.0; 363.0)n ¼ 697 98.8 (53.9) 86.0
(1.0; 364.0)n ¼ 331
0.0012
Biologic aortic valve 55 (7.1%) 14 (3.8%) 0.033
Proximal repair:
AV resuspension þ
ascending graft
291 (37.3%) 164 (44.2%)
AVR þ ascending graft 25 (3.2%) 9 (2.4%)
Ascending graft only 220 (28.2%) 124 (33.4%)
Attempted 7 (0.9%) 4 (1.1%)
Biological composite 43 (5.5%) 22 (5.9%)
Mechanical composite 164 (21.0%) 38 (10.2%)
Valve sparing root 24 (3.1%) 8 (2.2%)
Ascending graft only
prior AVR
6 (0.8%) 2 (0.5%) 0.0013
Distal repair:
Ascending aorta 543 (70.3%) 269 (73.1%)
Attempted 5 (0.6%) 5 (1.4%)
Hemiarch 171 (22.2%) 77 (20.9%)
Total arch 51 (6.6%) 15 (4.1%)
Other 2 (0.3%) 2 (0.5%) 0.27
Perioperative MI 45 (5.9%) 26 (7.1%) 0.52
Intraoperative death 52 (6.7%) 34 (9.1%) 0.17
Abbreviations: AV, aortic valve; AVR, aortic valve replacement; MI, myocardial infarction; SD, standard deviation.
Note: Data are presented as n (%) or mean (SD) / median (min; max).
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shown diverging results.3,9,10 A limited number of multi-
center studies, including the International Registry of Acute
Aortic Dissection (IRAD), have examined the association
between sex and outcome following surgical repair for aortic
dissection. In the IRAD registry, Nienaber et al9 found a
significantly higher in-hospital mortality among females as
compared with males (30.1% vs. 21.0%). However, the study
included a heterogeneous group of patients with Stanford
Type A and B dissections that were treated either medically
and/or surgically. When adjusting for Type A aortic dissec-
tion, females still presented worse outcome. The increased
mortality among females was suggested to be due to worse
preoperative characteristics and an increased time-delay
from symptom presentation to diagnosis as compared with
males, although no risk-adjusted analysis was presented.
In this study, we found a shorter delay in the time
duration from symptom presentation until definitive treat-
ment with surgery among females than that for males, yet
not statistically significant. A shorter delay in diagnosis
could indicate that females were more inclined to seek
medical attention on recognition of symptoms. However,
as for ischemic heart disease, females often present with
more atypical symptoms of ATAAD, resulting in misdiag-
nosis and treatment for other more common conditions,
such as acute coronary syndrome.13–15 It is well defined
that the mortality rate increases significantly with time in
patients with ATAAD, and a delay in diagnosis can have fatal
consequences.14
In a recent study by Melvinsdottir et al16 that included
both surgical cases and those diagnosed at autopsy, 35% of all
patients with ATAAD died prior to hospital arrival. In con-
sistency, another study reported that 49% of patients with
ATAAD had died before hospital assessment, whereof 61%
were females.17 Death prior to hospital arrival may have
influenced our results as we did not include these patients in
this study, thus possibly underestimating the incidence of
ATAAD and early fatality. Furthermore, females are found to
be older thanmales at the onset of ATAAD and thereforemay
havebeenmore prone tomedicalmanagement as opposed to
surgery.18
The study by Lee et al investigated operativemanagement
and outcomes of 2,983 patients with ATAAD in North Amer-
ica. They found that both age above 70 years and female sex
were independent predictors of mortality, in spite of the
higher occurrence of ATAAD among males in their study.
Nevertheless, the mean age for females and males was not
reported, and the primary aimwas not to study the effects of
sex on outcome.3 In most previous studies, the occurrence of
ATAAD has consistently been lower among females (with a
ratio of 1:2 or 1:3), who have also been found to be older with
an average age difference of 7 to 11 years4,5,9–11,16 and have
lower BMI as compared with males.4,5 In consistency with
previous studies, females were also significantly older, had
lower BMI, and more frequently had a history of hyperten-
sion and COPD in the present cohort. Females also presented
with significantly lower preoperative creatinine, although
within the normal range. Interestingly, and despite these
variances in patient characteristics,we found no difference in
mortality among sexes. When adjusting for perioperative
factors in a multivariable analysis, no difference was found
between sexes in 30-day mortality. In the same analysis, a
history of preoperative diabetes and COPD had an effect on
mortality. This however did not seem to affect outcome in
females, who more frequently presented with a history of
COPD.
Extensive aortic repair including aortic root and/or valve
replacement and/or aortic arch repair may also influence
outcome prognosis in patients. Nevertheless, and in contrast
to the NORCAAD, intraoperative characteristics were not
reported in most of the previous studies on sex differences
in ATAAD.4,9–11 In this study, HCA time were shorter among
females. This could be due to the increased incidence of total
arch procedures in males, although not statistically signifi-
cant. Furthermore, DeBakey Type I dissections were more
frequent among males, indicating a more widespread dis-
section of the aortic arch and distal aorta. Females less
frequently underwent extensive repair with valve replace-
ment compared with males, which most likely explains the
shorter duration of operation, CPB, and aortic cross-clamp
time in females. Alternatively, it could indicate that
Table 3 Postoperative characteristics
Variables Male (n ¼ 729) Female (n ¼ 339) p-Value
Reoperation bleeding 174 (23.9%) 56 (16.5%) 0.0050
Length of stay in ICU 6.11 (8.45)4.00 (0.00; 134.00)n ¼ 568 5.23 (5.81)3.00 (0.00; 40.00)n ¼ 275 0.17
Length of stay 12.5 (12.6)9.0 (0.0; 136.0)n ¼ 492 12.9 (13.0)9.0 (0.0; 96.0)n ¼ 211 0.88
Postoperative AF 289 (39.6%) 143 (42.2%) 0.66
Postoperative stroke 117 (16.0%) 60 (17.7%) 0.67
Postoperative TIA 35 (4.8%) 17 (5.0%) 1.00
Postoperative cardiac arrest 54 (7.4%) 24 (7.08%) 0.89
Death at discharge 128 (17.5%) 61 (17.9%) 1.00
30-day mortality 138 (18.9%) 65 (19.2%) 0.99
Abbreviations: AF, atrial fibrillation; ICU, intensive care unit; SD, standard deviation; TIA, transient ischemic attack.
Note: Data are presented as n (%) or mean (SD) / median (min; max).
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simplified procedures (supracoronary graft alone) were
more often performed in females, and if so, possible sex
bias. Such sex bias may have acted in a favorable direction:
greater age and increased preoperative comorbidity thus
counteracted by a swifter surgical procedure resulting in
equalized early mortality.
A longer life span among females may have contributed to
the increased occurrence of comorbidities such as hyperten-
sion.4 The incidence of hypertension, which increases with
age, is believed to play an important role in the pathogenesis
of ATAAD. However, and in consistency with previous stu-
dies, the incidence of ATAAD for males was twice that for
females, implying that females may be less prone to the
development of ATAAD.
Limitations and Strengths
This study included a subset of patients who reach desig-
nated tertiary referral centers alive. This is an important
limitation, as a substantial proportion of patients with
ATAAD who died prior to hospital admission may have
been missed, thereby underestimating overall incidence
and outcome. Importantly, data on the time duration from
the onset of symptoms until the surgical treatment were
often missing; therefore, these results have to be interpreted
carefully. Differences may have been present in the surgical
techniques used over time or among the different institu-
tions; however, ourmulticenter studyallowedus to include a
large cohort of surgical patients with Stanford Type A dis-
section. Furthermore, the uniform health care systems in the
Nordic countries ensured a relatively stable homogeneous
populations for which follow-up was successfully achieved.
Conclusions
In summary, this study, which is one of the largest to date,
found no sex-related differences in early mortality following
surgery for ATAAD. This is seen despite females being older
and havingmore comorbidities, but also presenting with less
widespread dissection than males. In line with previous
studies, females represented only one-third of the cohort,
implying that females may be better protected from the
development of ATAAD.
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